Rocket Lab’s Stock Rebounds as Japan Deal Joins Space Force Win, but the Damage Runs Deep
Published on 07/31/2026 at 00:20 | Redaktion boerse-global.de
Rocket Lab shares bounced 7.2% to €54.90 on Thursday after the company announced its third multi-launch contract with Japanese Earth-observation specialist iQPS in less than a year, adding three dedicated Electron missions to a rapidly filling order book. The uptick, which followed a similar 8.2% jump the previous day, offered a brief reprieve from a brutal 30-day stretch that wiped 37.75% from the stock’s value.
The iQPS agreement calls for launches from Rocket Lab’s New Zealand facility beginning in late 2027, each carrying a QPS-SAR satellite into a 575-kilometer low-Earth orbit. The company will also supply its Motorized Lightband separation system for satellite deployment. Since 2023, Rocket Lab has successfully delivered seven QPS-SAR satellites for iQPS with a perfect mission record, as the Japanese firm pursues an ambitious expansion to 24 satellites by May 2028 and 36 by 2030.
The deal comes hot on the heels of Monday’s announcement that Rocket Lab had secured the largest launch contract in its history — a $266 million award from the U.S. Space Force for at least 12 suborbital HASTE missions, with options for up to 18. Together, the two wins bring Rocket Lab’s booked mission manifest to 18 launches.
Yet the stock remains 58.59% below its May high of €133.80, a collapse that has left the shares trading 17.77% beneath their 200-day moving average of €67.37. The relative strength index sits at 34.8, deep in oversold territory and signaling that the selling pressure may have run its course — at least temporarily.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The Gap Between Operational Wins and Market Sentiment
The disconnect between Rocket Lab’s commercial momentum and its stock performance has become the defining narrative for the company. The order backlog now stands at $2.2 billion, and the firm is on pace for more than 20 launches this year. But the market has shifted its focus from growth promises to execution, demanding tangible revenue conversion rather than future ambitions.
Analysts remain broadly bullish, with a consensus price target of €99.21 — implying a 79.1% upside from current levels. But the annualized volatility of 95.73% underscores just how skittish the shareholder base has become.
The sell-off has been amplified by several factors beyond Rocket Lab’s operational control. Insider sales totaling over $360 million in the past quarter added significant supply to the market, while sector-wide noise around a potential SpaceX initial public offering created a gravitational pull on space-stock valuations. Comments from Elon Musk and NASA chief Jared Isaacman regarding lunar and Mars ambitions have provided some stabilization for the broader space sector, but Rocket Lab’s stock has been slower to recover.
Neutron Remains the Wild Card
The company’s next major catalyst — and its biggest risk — is the Neutron rocket for medium-lift cargo transport. Management targets a first flight by late 2026, but skeptics anticipate a delay into 2027. Any deviation from the Archimedes engine qualification timeline is likely to trigger fresh volatility, given the stock’s extreme sensitivity to schedule updates.
For now, Rocket Lab is evolving beyond a pure launch provider into a vertically integrated space systems company. Whether the market begins to price that transformation at €55.40 — or whether the recent rout proves to have been a rational repricing — will depend heavily on what management delivers when it reports second-quarter results on August 10.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
The Numbers That Matter Next
Analysts expect quarterly revenue of roughly $230 million, a 60% year-over-year increase, with a full-year 2026 forecast of $918 million representing approximately 52% growth. The iQPS contract, while not immediately revenue-generating, reinforces the recurring-launch model that underpins those projections.
One near-term operational wrinkle: Rocket Lab’s next launch for iQPS was aborted during ignition in late June, and a reattempt is not expected before August. The company’s perfect track record with the Japanese client remains intact, but any further delays could test investor patience.
At €54.90, Rocket Lab shares have priced in considerable skepticism. The combination of a record government contract, a deepening commercial relationship with iQPS, and an oversold technical picture gives the bulls a plausible argument that the sell-off overshot. But with the 200-day moving average broken and a 52-week decline of nearly 60%, the burden of proof now rests squarely on the August earnings report to show that the backlog is finally translating into cash.
Ad
Rocket Lab Stock: New Analysis - 31 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
